A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. [electronic resource]
Producer: 20030808Description: 115-23 p. digitalISSN:- 1537-3649
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Cardia -- pathology
- Docetaxel
- Dose-Response Relationship, Drug
- Esophageal Neoplasms -- drug therapy
- Female
- Humans
- Hypotension -- chemically induced
- Infusions, Intravenous
- Irinotecan
- Male
- Middle Aged
- Nausea -- chemically induced
- Paclitaxel -- administration & dosage
- Stomach Neoplasms -- drug therapy
- Taxoids
- Treatment Outcome
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.